Citi Reiterates Sell Rating on PTC Therapeutics (PTCT), 'PIVOT-HD Data Update Supportive, But Expectations Measured to this Point'
Go back to Citi Reiterates Sell Rating on PTC Therapeutics (PTCT), 'PIVOT-HD Data Update Supportive, But Expectations Measured to this Point'| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 70.64 +1.96 (2.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.68 | 52 Week High | $35.40 | |||
| Open | $69.54 | 52 Week Low | $4.03 | |||
| Day High | $71.73 | P/E | 7.51 | |||
| Day Low | $69.46 | EPS | $9.40 | |||
| Volume | 1,098,009 | |||||
